✦ LIBER ✦

Pilot Trial of Preoperative (Neoadjuvant) Letrozole in Combination With Bevacizumab in Postmenopausal Women With Newly Diagnosed Estrogen Receptor— or Progesterone Receptor—Positive Breast Cancer

✍ Scribed by Andres Forero-Torres; Mansoor N. Saleh; Janice A. Galleshaw; Cheryl F. Jones; Jatin J. Shah; Ivor J. Percent; Lisle M. Nabell; John T. Carpenter; Carla I. Falkson; Helen Krontiras; Marshall M. Urist; Kirby I. Bland; Jennifer F. De Los Santos; Ruby F. Meredith; Valerie Caterinicchia; Wanda K. Bernreuter; Janis P. O'Malley; Yufeng Li; Albert F. LoBuglio

Book ID: 119934844
Publisher: CIG Media Group, LP.
Year: 2010
Tongue: English
Weight: 661 KB
Volume: 10
Category: Article
ISSN: 1526-8209
DOI: 10.3816/cbc.2010.n.035

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neoadjuvant letrozole in postmenopausal

Neoadjuvant letrozole in postmenopausal estrogen and/or progesterone receptor positive breast cancer: A phase IIb/III trial to investigate optimal duration of preoperative endocrine therapy

✍ Ute E Krainick-Strobel; Werner Lichtenegger; Diethelm Wallwiener; Augustinus H T 📂 Article 📅 2008 🏛 BioMed Central 🌐 English ⚖ 275 KB

A phase II neoadjuvant trial of anastroz

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancer

✍ Suleiman Massarweh; Yee L. Tham; Jian Huang; Krystal Sexton; Heidi Weiss; Anna T 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 361 KB

Breast Conservation Rates and Outcomes i

Breast Conservation Rates and Outcomes in Postmenopausal Women With Estrogen Receptor-positive Breast Cancer Treated With Neoadjuvant Hormonal Therapy or Chemotherapy

✍ Marcus, D.M.; Prabhu, R.; O'Regan, R.; Zelnak, A.; Fasola, C.; Mister, D.; Torre 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 75 KB

BOLERO-2: Everolimus in combination with

BOLERO-2: Everolimus in combination with exemestane in the treatment of postmenopausal women with estrogen receptor-positive ADVANCED breast cancer refractory to letrozole or anastrozole

✍ Mario Campone; Martine Piccart; Kathleen I. Pritchard; Cindy Xu; Michael Gnant; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Pharmacoeconomic analysis of adjuvant th

Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer

✍ Juan Miguel Gil; Carlos Rubio-Terrés; Almudena del Castillo; Paloma González; Fe 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 827 KB

Histopathological assessment of anastroz

Histopathological assessment of anastrozole and tamoxifen as preoperative (neoadjuvant) treatment in postmenopausal Japanese women with hormone receptor-positive breast cancer in the PROACT trial

✍ Masafumi Kurosumi; Yuichi Takatsuka; Toru Watanabe; Shigeru Imoto; Hideo Inaji; 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 English ⚖ 357 KB